UT Southwestern Medical Center researchers find that an FDA-approved drug to treat high blood pressure seems to extend life span in worms via a cell signaling pathway that may mimic caloric restriction.
The drug, hydralazine, extended life span about 25 percent in two strains of C. elegans (roundworms), one a wild type and the other bred to generate high levels of a neurotoxic protein called tau that in humans is associated with Alzheimer’s disease.
“This is the first report of hydralazine treatment activating the NRF2/SKN-1 signaling pathway. We found the drug extends the life span of worms as well as or better than other potential anti-aging compounds such as curcumin and metformin. The treatment also appeared to maintain their health as measured by tests of flexibility and wiggling speed,” said Dr. Hamid Mirzaei, Assistant Professor of Biochemistry at UT Southwestern and senior author of the study, published today in Nature Communications.
The NRF2 pathway protects human cells from oxidative stress. The body’s ability to protect itself against damaging oxygen free radicals diminishes with age, he said.
One of the hallmarks of aging and neurodegenerative diseases such as Alzheimer’s and Parkinson’s is oxidative stress, which is believed to result cumulatively from inflammatory and infectious illnesses throughout life, Dr. Mirzaei explained. SKN-1, a C. elegans transcription factor, corresponds to NRF2 in humans. Both play a pivotal role in their respective species’ responses to oxidative stress and life span, he said.
The UT Southwestern researchers were searching for a chemical probe they could use in experiments to identify proteins that get oxidized and become toxic during aging. Their screen for a substance that would cross the blood-brain barrier and be nontoxic led them to hydralazine.
“Age-related neurodegenerative diseases are devastating, and those conditions are on the rise due to the increase in the life span of humans. For that reason, it is important to develop treatments to maintain human health as long as possible,” said Dr. Mirzaei, who is also an investigator in the Center for Alzheimer’s and Neurodegenerative Diseases, part of the Peter O’Donnell Jr. Brain Institute at UT Southwestern.
The researchers did in vivo (in a living creature) and in vitro (in a lab dish) studies on the worms and also studied human cells from a pediatric cancer called neuroblastoma. Compared with untreated controls, roundworms treated with the drug showed about a 25 percent increase in life span (from 15-18 days to about 20-23 days), the team reported.
The results of a series of biochemical experiments indicated that the hydralazine-linked life span extension was dependent on the worms’ SKN-1 pathway via a mechanism that appeared to mimic caloric restriction, he said.
To test the potency of hydralazine in the context of neurodegenerative disease, the scientists used a high dose of a chemical stressor called rotenone that is associated with increased risk of Parkinson’s disease in humans exposed to high doses. They found that hydralazine provided a significant amount of neuroprotection, Dr. Mirzaei said. The drug also showed a significant decrease in tau toxicity in the C. elegansmodel of Alzheimer’s disease, he added.
“Based on these results, we suggest that hydralazine may be a good candidate for clinical trials for the treatment of age-related disorders in humans as it may also offer general health benefits to the aging population,” he said.
He stressed that this study is a promising first step, but further studies are needed to corroborate it.
The Latest on: Life extension
- Hope for North Perth childcare service to receive life extensionon January 30, 2020 at 9:21 pm
THE City of Vincent will ask Attorney General John Quigley to extend the life of Kidz Galore Pty Ltd at its North Perth home before it has to make way for parkland at Haynes Street Reserve.
- All American Marine to Perform Life Extension Program on USCG Boatson January 30, 2020 at 6:23 pm
All American Marine, Inc. (AAM) has been named the West Coast shipyard by Birdon America, Inc., for Phase I of a contract to perform a Service Life Extension Program (SLEP) on a number of United ...
- The Bizarre Fight Over a Wealthy Biochemist’s Frozen Head Keeps Getting Weirderon January 18, 2020 at 2:00 am
Until his death, Dr. Laurence Pilgeram, a biochemist and medical school professor, was a longtime proponent of the Arizona-based Alcor Life Extension Foundation’s cryonics program. The company ...
- Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Techon January 13, 2020 at 5:30 am
The clinically validated platform—XTEN—is a proprietary unstructured polypeptide, which when attached to molecules, can extend the half-life of drugs with low associated immunogenicity ...
- Equinor Announces Giant Life-Extension Program for Statfjordon January 9, 2020 at 4:00 pm
The Statfjord A platform will get a life extension until 2027, and Statfjord B and C will be kept running beyond 2035. It is the latest in a long string of reprieves for Statfjord A, which was ...
- Living Up to Our Potential: The Quest for Human Life Extensionon January 9, 2020 at 7:41 am
Elena Milova, Board Member and Outreach Officer of the Life Extension Advocacy Foundation (LEAF) and the crowdfunding platform Lifespan.io, is at the forefront of this movement and is helping ...
- Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodieson January 8, 2020 at 1:05 pm
Half-life extension was observed in all dogs across all groups other than the wild type, with the magnitude of extension over native antibody ranging from two to three-fold. Additional studies to ...
- Unit 4 of Novovoronezh NPP received a life extension license from Rostechnadzoron January 7, 2020 at 10:08 pm
On December 29, the Federal Environmental, Industrial and Nuclear Supervision Service Rostechnadzor issued a second additional service life extension license for Unit 4 of Novovoronezh NPP for 13 ...
- FuelCell Energy Provides Update on Successful Development and Launch of Seven Year Extended Life Stack Moduleson January 5, 2020 at 4:00 pm
The life extension effort was a key focus of the company’s Internal R&D efforts delivering on the transition. The effort was also partially supported by the US Department of Energy through the ...
via Google News and Bing News